[ad_1]
The Chinese company “Sinovac Biotec” for the pharmaceutical industry announced that it will intensify its production of the Chinese vaccine “Coronavac” against Corona, in response to strong global demand due to the imbalance in supplies of the vaccine “Pfizer Biontech”.
“Sinovac is stepping up production of the Coronavac vaccine … to ensure global supply,” said Yin Weidong, president and CEO of the company, according to China’s “Xinhua” news agency, adding that “Sinovac” received requests from Brazil, Indonesia, Turkey, Chile and other countries and regions. “He reassured the partners saying:” We are making every effort to expand production capacity and we hope that the vaccine will protect more people around the world. ” . annual production capacity at one billion doses. “
In order to expedite response to vaccine requests, Yin Weidong explained that “Sinovac” will export the doses to some countries without completing the last stages of the pre-export production process, such as packaging and packaging, as leaves them. to importing countries, because the fluctuating situation related to the development of the virus requires, according to the Chinese official, “Do not we respond to it only with the usual business model of supply and demand? Vaccines are public goods and we must assume social responsibilities . “
It should be noted that several countries around the world have given their approval for the emergency use of the Chinese “Coronavac” vaccine, including China, the producing country, Indonesia, Brazil and Chile.
Source: “Xinhua” / Chinese “People” newspaper
[ad_2]
